Brian CFA - Surgepays Managing MZ
| SURG Stock | USD 1.86 0.12 6.06% |
Insider
Brian CFA is Managing MZ of Surgepays
| Address | 3124 Brother Boulevard, Bartlett, TN, United States, 38133 |
| Phone | 901 302 9587 |
| Web | https://surgepays.com |
Surgepays Management Efficiency
The company has return on total asset (ROA) of (0.0151) % which means that it has lost $0.0151 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.0519) %, meaning that it created substantial loss on money invested by shareholders. Surgepays' management efficiency ratios could be used to measure how well Surgepays manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Surgepays' Return On Assets are most likely to increase significantly in the upcoming years. At this time, Surgepays' Non Current Assets Total are most likely to increase significantly in the upcoming years. The Surgepays' current Non Currrent Assets Other is estimated to increase to about 213.5 K, while Intangible Assets are projected to decrease to roughly 2 M.Similar Executives
| Showing other executives | INSIDER Age | ||
| Sean Hopkins | Versus Systems | 48 | |
| Dawn Newsome | Envestnet | N/A | |
| Chris Shutler | Envestnet | N/A | |
| Javier Selgas | Freight Technologies | 39 | |
| David Barrett | Expensify | 47 | |
| Luisa Lopez | Freight Technologies | N/A | |
| Norman Poh | Trust Stamp | 48 | |
| Joon Park | Clearwater Analytics Holdings | N/A | |
| Mary Dugan | Envestnet | N/A | |
| Matthew Pierce | Versus Systems | 46 | |
| Amanda Armour | Versus Systems | 42 | |
| Dana DAuria | Envestnet | N/A | |
| Souvik Das | Clearwater Analytics Holdings | 53 | |
| Russell Vanderhook | Viant Technology | N/A | |
| Linh Chung | Viant Technology | N/A | |
| Cindy Blendu | Clearwater Analytics Holdings | 47 | |
| Laura Webb | Versus Systems | N/A | |
| Sharon Rosenthal | Envestnet | N/A | |
| James Cox | Clearwater Analytics Holdings | 52 | |
| Stuart DePina | Envestnet | 59 | |
| Gareth Genner | Trust Stamp | 64 | |
Management Performance
| Return On Equity | -0.0519 | ||||
| Return On Asset | -0.0151 |
Surgepays Leadership Team
Elected by the shareholders, the Surgepays' board of directors comprises two types of representatives: Surgepays inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Surgepays. The board's role is to monitor Surgepays' management team and ensure that shareholders' interests are well served. Surgepays' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Surgepays' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Kevin Cox, Chairman of the Board, CEO | ||
| Carter Matzinger, Chief LogicsIQ | ||
| CPA CIA, CFO COO | ||
| John Mott, Chief Officer | ||
| Brian CFA, Managing MZ | ||
| MBA JD, Secretary Services | ||
| Jeremy Gies, I Fintech |
Surgepays Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Surgepays a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.0519 | ||||
| Return On Asset | -0.0151 | ||||
| Profit Margin | (0.01) % | ||||
| Operating Margin | (0.72) % | ||||
| Current Valuation | 20.69 M | ||||
| Shares Outstanding | 20.16 M | ||||
| Shares Owned By Insiders | 31.90 % | ||||
| Shares Owned By Institutions | 8.72 % | ||||
| Number Of Shares Shorted | 361.27 K | ||||
| Price To Earning | 11.14 X |
Currently Active Assets on Macroaxis
When determining whether Surgepays is a strong investment it is important to analyze Surgepays' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Surgepays' future performance. For an informed investment choice regarding Surgepays Stock, refer to the following important reports:Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Surgepays. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. For more detail on how to invest in Surgepays Stock please use our How to Invest in Surgepays guide.You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Is Wireless Telecommunication Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Surgepays. If investors know Surgepays will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Surgepays listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.78) | Earnings Share (1.18) | Revenue Per Share 6.864 | Quarterly Revenue Growth (0.58) | Return On Assets (0.02) |
The market value of Surgepays is measured differently than its book value, which is the value of Surgepays that is recorded on the company's balance sheet. Investors also form their own opinion of Surgepays' value that differs from its market value or its book value, called intrinsic value, which is Surgepays' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Surgepays' market value can be influenced by many factors that don't directly affect Surgepays' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Surgepays' value and its price as these two are different measures arrived at by different means. Investors typically determine if Surgepays is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Surgepays' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.